Research Projects & Grants

College/University

  • Diet and Replace Risk in Pediatric Multiple Sclerosis, Role: PD/PI, University of San Francisco, (10/2017 - 09/2020) Status: Awarded
  • Patient-family Views on Pediatric MS Research Needs, Outcomes, and Methods, Role: Principal Investigator, Massachusetts General Hospital, (06/2018 - 12/2022) Status: Awarded
  • Pediatric Data Coordinating and Analysis Center, Role: Principal Investigator, University of Utah, (07/2016 - 06/2019) Status: Closed
  • Pediatric Data Coordinating and Analysis Center, Role: Principal Investigator, University of Utah, (12/2012 - 06/2017) Status: Closed
  • Environmental and Genetic Risk Factors for Pediatric Mutliple Sclerosis, Role: Principal Investigator, University of California, San Francisco, (05/2011 - 04/2017) Status: Closed
  • ENVIRONMENTAL AND GENETIC RISK FACTORS FOR PEDIATRIC MULTIPLE SCLEROSIS, Role: Principal Investigator, University of Southern California, (01/2010 - 12/2010) Status: Awarded

For Profit Organization

  • Open Label, Multicenter, Multiple Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis Aged 10 to 17 Years, Role: Principal Investigator, Biogen, Inc., Status: Awarded
  • A Multicenter Extension Study to Determine the Long-Term Safety and Efficacy of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (109MS311), Role: Principal Investigator, Biogen, Inc., Status: Closed
  • (CDA) UCB Biopharma / Dr. Gregory Aaen, Role: Principal Investigator, UCB Biopharma SPRL, Status: Awarded
  • An Open-label, Parallel-group Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Ocrelizumab in Children and Adolescents with Relapsing-remitting Multiple Sclerosis, Role: Principal Investigator, Hoffmann-La Roche Inc., Status: Awarded
  • (CDA) Novartis Pharmaceuticals / Dr. Gregory Aaen, Role: PD/PI, Novartis Pharmaceuticals Corporation, Status: Awarded
  • (CDA) Horizon Therapeutics (PPDI) / Dr. Gregory Aaen, Role: PD/PI, Horizon Therapeutics, Inc., Status: Awarded

Non-Profit Organization

  • (CDA) EMD Serono, Inc. / Dr. Gregory Aaen, Role: Principal Investigator, EMD Serono/Merck, Status: Awarded
  • (CDA) IQVIA / Biogen / Dr. Gregory Aaen, Role: PD/PI, IQVIA RDS Inc., Status: Awarded
  • (CDA) Biogen, Inc. (CRO-IQVIA) / Dr. Gregory Aaen, Role: PD/PI, IQVIA RDS Inc., Status: Awarded
  • Treatment Adherence in Pediatric Multiple Sclerosis: Project 5982896, Role: Principal Investigator, Hospital for Sick Children Foundation, (02/2014 - 09/2016) Status: Closed